Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andria L Del Tredici

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Methods in Enzymology|November 6, 2010
Inverse agonist activity of steroidogenic factor SF-1Fabrice Piu, Andria L Del Tredici
The Journal of Pharmacology and Experimental Therapeutics|November 9, 2013
Identification of the antiarrhythmic drugs amiodarone and lorcainide as potent H3 histamine receptor inverse agonistsAndria L Del Tredici, Jian-Nong Ma, Fabrice Piu, et al.
Organic & Biomolecular Chemistry|April 19, 2008
Synthesis and evaluation of novel pyridine based PLG tripeptidomimeticsStina Saitton, Andria L Del Tredici, Maria Saxin, et al.
Pharmacogenomics and Personalized Medicine|October 16, 2020
Genetic Testing for <i>BCHE</i> Variants Identifies Patients at Risk of Prolonged Neuromuscular Blockade in Response to SuccinylcholineGuang-Dan Zhu, Eric Dawson, Angela Huskey, et al.
Journal of Medicinal Chemistry|December 14, 2004
Design, synthesis and evaluation of a PLG tripeptidomimetic based on a pyridine scaffoldStina Saitton, Andria L Del Tredici, Nina Mohell, et al.
The Journal of Molecular Diagnostics : JMD|February 24, 2018
Recommendations for Clinical CYP2C19 Genotyping Allele Selection: A Report of the Association for Molecular PathologyVictoria M Pratt, Andria L Del Tredici, Houda Hachad, et al.
Frontiers in Pharmacology|April 21, 2018
Frequency of <i>CYP2D6</i> Alleles Including Structural Variants in the United StatesAndria L Del Tredici, Alka Malhotra, Matthew Dedek, et al.
The Pharmacogenomics Journal|September 4, 2021
Impact of genetic variation in CYP2C19, CYP2D6, and CYP3A4 on oxycodone and its metabolites in a large database of clinical urine drug testsGuang-Dan Zhu, Penn Whitley, Leah LaRue, et al.
Biochemical Pharmacology|March 24, 2004
Pharmacology of polymorphic variants of the human 5-HT1A receptorAndria L Del Tredici, Hans H Schiffer, Ethan S Burstein, et al.
Frontiers in Pharmacology|April 12, 2019
A Screening Test for <i>HLA-B</i> in a Large United States Patient Cohort Identifies Broader Risk of Carbamazepine-Induced Adverse EventsHua Fang, Xiequn Xu, Kulvinder Kaur, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Methods in Enzymology|November 6, 2010
Inverse agonist activity of steroidogenic factor SF-1Fabrice Piu, Andria L Del Tredici
The Journal of Pharmacology and Experimental Therapeutics|November 9, 2013
Identification of the antiarrhythmic drugs amiodarone and lorcainide as potent H3 histamine receptor inverse agonistsAndria L Del Tredici, Jian-Nong Ma, Fabrice Piu, et al.
Organic & Biomolecular Chemistry|April 19, 2008
Synthesis and evaluation of novel pyridine based PLG tripeptidomimeticsStina Saitton, Andria L Del Tredici, Maria Saxin, et al.
Pharmacogenomics and Personalized Medicine|October 16, 2020
Genetic Testing for <i>BCHE</i> Variants Identifies Patients at Risk of Prolonged Neuromuscular Blockade in Response to SuccinylcholineGuang-Dan Zhu, Eric Dawson, Angela Huskey, et al.
Journal of Medicinal Chemistry|December 14, 2004
Design, synthesis and evaluation of a PLG tripeptidomimetic based on a pyridine scaffoldStina Saitton, Andria L Del Tredici, Nina Mohell, et al.
The Journal of Molecular Diagnostics : JMD|February 24, 2018
Recommendations for Clinical CYP2C19 Genotyping Allele Selection: A Report of the Association for Molecular PathologyVictoria M Pratt, Andria L Del Tredici, Houda Hachad, et al.
Frontiers in Pharmacology|April 21, 2018
Frequency of <i>CYP2D6</i> Alleles Including Structural Variants in the United StatesAndria L Del Tredici, Alka Malhotra, Matthew Dedek, et al.
The Pharmacogenomics Journal|September 4, 2021
Impact of genetic variation in CYP2C19, CYP2D6, and CYP3A4 on oxycodone and its metabolites in a large database of clinical urine drug testsGuang-Dan Zhu, Penn Whitley, Leah LaRue, et al.
Biochemical Pharmacology|March 24, 2004
Pharmacology of polymorphic variants of the human 5-HT1A receptorAndria L Del Tredici, Hans H Schiffer, Ethan S Burstein, et al.
Frontiers in Pharmacology|April 12, 2019
A Screening Test for <i>HLA-B</i> in a Large United States Patient Cohort Identifies Broader Risk of Carbamazepine-Induced Adverse EventsHua Fang, Xiequn Xu, Kulvinder Kaur, et al.
Pageof 3